Profitability
Weight: 20%
B-
62
- 5yr Avg ROIC 7.3%
- Operating Margin Trend +2.29 pp/yr
HAE
Haemonetics Corporation
AlphaQuality composite grade, weighted for stable earnings power businesses.
Capital Efficiency
Weight: 15%
B+
80
- 5yr Avg ROE 13.6%
- 5yr Share-Count CAGR -2.0%
Growth Quality
Weight: 15%
A-
84
- 5yr Revenue CAGR 7.7%
- 5yr EPS CAGR 25.0%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 15%
A-
82
- 5yr FCF Margin 12.1%
- 5yr FCF/NI Conversion 1.53x
Balance Sheet
Weight: 20%
B-
65
- Net Debt / EBITDA 2.47x
- Interest Coverage (EBIT/Int) 8.41x
- Altman Z-Score 2.46
Stability
Weight: 15%
B-
62
- EPS Volatility (σ/μ) 0.47
- Piotroski F-Score 8
- Negative-Revenue Years (5) 1/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.5 of 5 gurus held; 4 added; 1 trimmed.
- Holders
- 5 +1
- Avg Δ position
- +179.4%
- New buys
- 0
- Full exits
- 0
- Laffont increased +606%
- Greenblatt increased +160%
- Wood decreased -93%